article thumbnail

Sanofi snaps up acne vaccine developer Origimm Bio

pharmaphorum

Sanofi said it would also apply its mRNA vaccine platform – acquired along with Translate Bio earlier this year – to find other acne vaccine candidates that could start clinical trials in 2023. Origimm’s expertise in the skin microbiome and antigen discovery will be central to that effort, it added.

article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

GSK’s Top 5 Best-Selling Drugs of 2022: 1) Shingrix (zoster vaccine recombinant, adjuvanted) Shingrix, with 2022 sales of £2.96 Clinical trials have shown that the vaccine is 90 percent effective in preventing shingles for individuals aged 50 and over. It is one of the largest generic drug manufacturers in the world.

Sales 98